Dapagliflozin (DAPA) Effects in HFpEF | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dapagliflozin (DAPA) Effects in HFpEF | stella

Back to Heart Failure With Preserved Ejection Fraction trials

Completed

Plain-English translation of NCT04730947 on ClinicalTrials.gov ↗ · Source last updated October 2023 · How we translate trials

Read our Heart failure research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Results

Read the full plain-English summary of this trial →

Key details

Phase

Testing effectiveness

Sponsor

Mayo Clinic

Enrollment target

~38 participants

Started

February 2021

Primary completion

November 2022

Age range

18 Years and older

Last updated on clinicaltrials.gov in October 2023.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.